Arrowhead Pharmaceuticals Inc (ARWR)

SG&A Expense Growth

14.25%

Quarterly · Period ending:

ARWR logo

ARWR SG&A Expense Growth

Latest reported14.25%
ARWR Quarterly SG&A Growth (QoQ) (0.00% → 14.25%)
High-resolution chart · PNG

ARWR sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrowhead Pharmaceuticals Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-27.1411%
-36.5498%
16.2975%
24.9487%
-12.7657%
-15.4383%
88.33%
-91.3043%
1,050%
0.005%
0%
299.99%
-150%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.